Midodrin Zentiva (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrin Zentiva, is a alpha-1 adrenergic agonist presented as an oral tablet for oral use. It treats orthostatic hypotension in adults by raising standing blood pressure and reducing dizziness or fainting. GNH USA supplies Midodrin Zentiva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine acts on the peripheral vascular system to counteract low blood pressure associated with standing. - Orthostatic hypotension: increases standing systolic blood pressure, reducing dizziness and risk of syncope. - Neurogenic orthostatic hypotension: improves autonomic regulation of vascular tone in patients with autonomic failure. - Hypotension due to autonomic dysfunction: supports blood pressure stability when nervous system control is impaired.

Midodrine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Piloerection (goose‑flesh skin) - Pruritus (itching) - Urinary retention - Supine hypertension - Paresthesia (tingling sensations) - Nausea or abdominal discomfort

Serious or Rare Side Effects: - Severe hypertension, especially when lying down - Bradycardia or cardiac arrhythmias - Myocardial infarction or acute coronary syndrome - Pulmonary edema - Anaphylaxis or severe allergic reactions - Ischemic complications in peripheral tissues

Before prescribing Midodrin Zentiva, clinicians should consider several safety measures. - Blood pressure monitoring: check supine and standing pressures regularly. - Supine positioning: advise patients to avoid lying flat for prolonged periods. - Renal impairment: adjust use in patients with reduced kidney function. - Cardiac disease: use cautiously in severe heart failure or recent myocardial infarction. - Contraindicated in pheochromocytoma: avoid in patients with this catecholamine‑secreting tumor. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Midodrin Zentiva can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Clonidine: opposing effects on blood pressure may cause severe fluctuations. - Other vasopressors (e.g., norepinephrine): additive pressor effect leading to extreme hypertension. - Tricyclic antidepressants: potentiation of vasoconstriction.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (ACE inhibitors, ARBs, diuretics): may blunt therapeutic effect. - Beta‑blockers: combined effect on heart rate and blood pressure. - Selective serotonin reuptake inhibitors (SSRIs): possible additive pressor response. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may affect renal handling of blood pressure.